Ascend, through its parent Alkem has two research and development facilities in India employing over 500 scientists including over 100 at the level of PhD. Our current efforts have resulted in 23 US approved molecules which when considering all the strengths and sizes total over 100 SKU’s. Additionally, we have completed the development of an additional 54 molecule’s which have been submitted to FDA and await approval. Another 100 plus molecules are under development at various stages and upon completion will also be submitted to FDA for approval.
Included among our assets is our own CRO (Contract Research Organization) where we are able to conduct our own biostudies in a brand new state of the art 100 bed hospital setting.
Our manufacturing facilities in India include campuses in Daman, about a three hour ride north of Mumbai and in Baddi in northern India in the foothills of the Himalaya Mountains. These facilities include general prescription tablet and capsule manufacturing as well as a penicillin block, a cephalosporin block and an immunosuppressant block.
In the USA our facilities in CA manufacture the Active Pharmaceutical Ingredients (API) for a number of current and under development products while our facilities in MO allow for both general and specialized manufacturer of prescription products including tablets and capsules, nasal sprays, ointments and creams and liquids.
Our continued goal is always to insure we have the capability to meet demand for the important products we bring to market.
To view the state-of the art manufacturing facilities, click here